Equities

OSI Systems Inc

OSI Systems Inc

Actions
IndustrialsElectronic & Electrical Equipment
  • Price (USD)94.26
  • Today's Change1.65 / 1.78%
  • Shares traded90.57k
  • 1 Year change-2.51%
  • Beta0.7197
Data delayed at least 15 minutes, as of Jan 25 2021 21:00 GMT.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

OSI Systems, Inc., through its subsidiaries, is a vertically integrated designer and manufacturer of specialized electronic systems and components for critical applications. The Company sells its products and provides related services in diversified markets, including homeland security, healthcare, defense and aerospace. The Company operates in three segments, which include Security, which provides security and inspection systems, turnkey security screening solutions and related services; Healthcare, which provides patient monitoring, diagnostic cardiology, anesthesia delivery and ventilation systems and defibrillators, and Optoelectronics and Manufacturing, which provides electronic components and electronic manufacturing services for the Security and Healthcare divisions, as well as to external original equipment manufacturer (OEM) customers and end users for applications in the defense, aerospace, medical and industrial markets, among others.

  • Revenue in USD (TTM)1.13bn
  • Net income in USD63.85m
  • Incorporated2010
  • Employees6.76k
  • Location
    OSI Systems Inc12525 Chadron AveHAWTHORNE 90250United StatesUSA
  • Phone+1 (310) 978-0516
  • Fax+1 (302) 655-5049
  • Websitehttps://www.osi-systems.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Luna Innovations Incorporated76.25m6.94m354.64m277.0053.404.8237.554.650.21540.16812.402.380.8533.473.57285,568.607.76-0.97739.35-1.2751.4242.539.10-1.223.57--0.0005--64.3127.10415.76--16.20--
Accelerate Diagnostics Inc11.53m-80.63m500.72m275.00------43.45-1.46-1.460.2081-0.8710.09170.7734.3941,909.09-64.12-54.88-67.67-57.5441.85---699.62-1,783.9511.68-4.861.53--63.97137.904.55---29.78--
Fluidigm Corporation125.98m-47.68m507.72m566.00--3.34--4.03-0.675-0.6751.782.050.42532.957.97222,572.40-16.10-19.56-18.47-21.7659.5355.22-37.85-56.902.41-13.030.2626--3.790.1348-9.79---19.32--
Diebold Nixdorf Inc3.95bn-340.50m984.96m22.00k------0.2495-4.40-4.4051.02-10.381.055.136.21179,454.50-9.07-5.49-15.29-9.6826.3022.96-8.64-5.710.89570.34171.48---3.7110.0236.63---6.52--
CTS Corporation416.09m29.80m1.12bn3.57k38.102.7119.952.690.91180.911812.7312.830.63826.475.29116,551.504.575.925.387.2632.4634.147.167.292.3419.110.204316.83-0.31543.03-21.736.3910.915.92
MTS Systems Corporation828.59m-272.05m1.16bn3.60k--5.22--1.40-14.11-14.1142.9611.480.67693.163.99230,162.80-22.22-2.52-28.64-3.1934.8037.12-32.83-3.591.101.620.7258---7.168.00-751.24--5.31-12.94
FARO Technologies, Inc.314.96m-76.47m1.36bn1.82k--4.33--4.30-4.36-4.3617.8317.570.65632.715.61173,243.10-15.94-10.17-19.76-12.2948.47---24.28-16.042.51-79.120.0016---5.422.23-1,360.59---15.11--
IMPINJ Inc143.30m-43.89m1.41bn272.00--12.87--9.86-1.94-1.946.354.760.78632.046.74526,823.50-24.08-11.89-27.13-14.1547.2250.30-30.63-12.906.44-8.680.3288--24.6319.1134.75--19.02--
Mesa Laboratories, Inc.127.66m-2.41m1.48bn460.00--3.76102.0211.56-0.6945-0.694526.7676.680.26025.648.29277,530.40-0.4923.06-0.51083.4458.7057.56-1.895.6913.740.86480.26743.4514.1110.53-82.08-32.44-11.930.637
OSI Systems, Inc.1.13bn63.85m1.66bn6.76k26.832.9815.071.473.453.4561.2131.130.88252.724.54167,224.004.993.436.974.9836.9235.265.653.831.086.240.36560.00-1.364.0016.142.929.42--
908 Devices Inc.29.53m-3.19m1.71bn96.00------58.08-0.0994-0.09940.92140.1711------307,552.10--------56.49---10.44--2.40-2.270.7299---18.51---77.12------
BioNano Genomics Inc7.30m-37.28m1.78bn97.00--99.06--243.80-0.7484-0.74840.10170.09890.2411.281.4875,290.00-123.02---262.66--36.88---510.42--0.9946-12.830.5218---15.59---61.19------
Quanterix Corp76.16m-32.67m2.46bn248.00--11.74--32.30-1.17-1.172.636.620.34652.963.99307,112.90-14.86---16.61--52.52---42.89--7.18--0.0353--50.76---29.36------
Data as of Jan 25 2021. Currency figures normalised to OSI Systems Inc's reporting currency: US Dollar USD

Institutional shareholders

55.82%Per cent of shares held by top holders
HolderShares% Held
BlackRock Fund Advisorsas of 30 Sep 20202.60m14.50%
Janus Capital Management LLCas of 30 Sep 20201.84m10.25%
The Vanguard Group, Inc.as of 30 Sep 20201.66m9.27%
Dimensional Fund Advisors LPas of 30 Sep 2020918.40k5.13%
Granahan Investment Management, Inc.as of 30 Sep 2020638.56k3.56%
T. Rowe Price Associates, Inc. (Investment Management)as of 30 Sep 2020569.56k3.18%
SSgA Funds Management, Inc.as of 30 Sep 2020545.58k3.04%
Credit Suisse Securities (USA) LLC (Broker)as of 30 Sep 2020430.33k2.40%
Credit Suisse Asset Management (Schweiz) AGas of 31 Dec 2020408.42k2.28%
Neumeier Poma Investment Counsel LLCas of 30 Sep 2020396.57k2.21%
More ▼
Data from 30 Sep 2020 - 31 Dec 2020Source: FactSet Research Systems Inc.
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.